Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOpioid that also blocks noradrenaline reuptake.Moderate opioid with antidepressant-like actions.
Body systemPain & FeverPain & Fever
Drug classOpioidsOpioids
SupplyControlled drugControlled drug
Main usesModerate to severe acute pain, Chronic severe pain, Painful diabetic neuropathy (extended-release)Moderate to severe pain, Pain after surgery, Osteoarthritis pain (short term)
How it worksStrong painkiller with a second action on nerve signalling.Acts on opioid receptors and on the brain's pain-dampening chemicals.
Starts working30–60 minutesAbout 1 hour
Half-lifeAbout 4 hoursAbout 6 hours
Typical adult dose50–100 mg every 4–6 hours (immediate-release); extended-release 50–250 mg twice a day.50–100 mg every 4–6 hours, maximum 400 mg a day (lower in older adults and kidney disease).
FormsTablet, Extended-release tabletCapsule, Tablet, Modified-release tablet, Injection, Orodispersible tablet
Common side effectsNausea, Dizziness, Constipation, Drowsiness, HeadacheNausea, Dizziness, Constipation, Sweating, Drowsiness, Headache
Serious side effectsSlow breathing, Seizures, Serotonin syndrome, DependenceSeizures, Serotonin syndrome, Slowed breathing, Dependence, Low blood sugar
Don't take ifTaking MAOIs (or within 2 weeks); Severe asthma; Paralytic ileus; Uncontrolled epilepsyUncontrolled epilepsy or a history of seizures; Taking an MAOI or within 14 days of stopping one; Severe breathing problems; Under 12 years of age
AlcoholBest avoided. Alcohol adds to dangerous drowsiness and breathing depression.Best avoided. Alcohol adds to drowsiness and breathing depression and can raise seizure risk.
PregnancyUsually avoidedAvoid in pregnancy unless essential.Use with cautionAvoid unless clearly needed; withdrawal can occur in the newborn.
BreastfeedingUsually avoidedAvoid.Usually avoidedPasses into milk; can sedate the baby. Avoid.
In use since—1977
Brand namesUnited States: NucyntaUnited Kingdom: PalexiaIndia: Tapal, NucyntaUnited States: Ultram, Ultracet (with paracetamol)United Kingdom: Zydol, Tramacet (with paracetamol)India: Contramal, Ultracet
Legal statusUnited States: Controlled substance (Schedule II)United Kingdom: Controlled drug (Schedule 2)India: Schedule H1 (NDPS scheduling recommended in 2025; no notification found)United States: Controlled substance (Schedule IV)United Kingdom: Controlled drug (Schedule 3)India: Schedule H1 (sales are recorded)
ATC codeN02AX06N02AX02

Taken together

  • MajorTapentadol + Tramadol: Dangerous drowsiness and slowed breathing

    Opioids combined with other opioids, benzodiazepines, gabapentinoids, sleeping tablets or sedating medicines can stop breathing. Many fatal overdoses involve such combinations.

  • ModerateTapentadol + Tramadol: Serotonin syndrome risk

    Both medicines raise serotonin. Most combinations are tolerated, but the risk of serotonin toxicity rises, particularly when starting or increasing doses.

  • ModerateTapentadol + Tramadol: Increased seizure risk

    Both medicines lower the seizure threshold.

  • ModerateTapentadol + Tramadol: Serotonin toxicity

    Some opioids, especially tramadol and fentanyl, add serotonergic activity to antidepressants and other serotonin-raising medicines.

Open in the interaction checker